|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/03/17 Morgan Stanley 10-Q 9/30/17 124:39M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 2.65M
2: EX-12 Statement re: Computation of Ratios HTML 59K
3: EX-15 Letter re: Unaudited Interim Financial Info HTML 46K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 42K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 42K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 37K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 37K
14: R1 Document and Entity Information HTML 63K
15: R2 Consolidated Income Statements (Unaudited) HTML 152K
16: R3 Consolidated Comprehensive Income Statements HTML 67K
(Unaudited)
17: R4 Consolidated Balance Sheets (Unaudited) HTML 136K
18: R5 Consolidated Balance Sheets (Unaudited) HTML 71K
(Parenthetical)
19: R6 Consolidated Statements of Changes in Total Equity HTML 94K
(Unaudited)
20: R7 Consolidated Cash Flow Statements (Unaudited) HTML 161K
21: R8 Introduction and Basis of Presentation HTML 51K
22: R9 Significant Accounting Policies HTML 48K
23: R10 Fair Value Disclosures HTML 1.55M
24: R11 Derivative Instruments and Hedging Activities HTML 598K
25: R12 Investment Securities HTML 511K
26: R13 Collateralized Transactions HTML 252K
27: R14 Loans and Allowance for Credit Losses HTML 326K
28: R15 Equity Method Investments HTML 62K
29: R16 Deposits HTML 61K
30: R17 Long-Term Borrowings and Other Secured Financings HTML 61K
31: R18 Commitments, Guarantees and Contingencies HTML 229K
32: R19 Variable Interest Entities and Securitization HTML 366K
Activities
33: R20 Regulatory Requirements HTML 164K
34: R21 Total Equity HTML 386K
35: R22 Earnings per Common Share HTML 129K
36: R23 Interest Income and Interest Expense HTML 97K
37: R24 Employee Benefit Plans HTML 70K
38: R25 Income Taxes HTML 44K
39: R26 Segment and Geographic Information HTML 91K
40: R27 Subsequent Events HTML 40K
41: R28 Significant Accounting Policies (Policy) HTML 48K
42: R29 Fair Value Disclosures (Tables) HTML 1.57M
43: R30 Derivative Instruments and Hedging Activities HTML 602K
(Tables)
44: R31 Investment Securities (Tables) HTML 510K
45: R32 Collateralized Transactions (Tables) HTML 257K
46: R33 Loans and Allowance for Credit Losses (Tables) HTML 334K
47: R34 Equity Method Investments (Tables) HTML 59K
48: R35 Deposits (Tables) HTML 61K
49: R36 Long-Term Borrowings and Other Secured Financings HTML 59K
(Tables)
50: R37 Commitments, Guarantees and Contingencies (Tables) HTML 177K
51: R38 Variable Interest Entities and Securitization HTML 366K
Activities (Tables)
52: R39 Regulatory Requirements (Tables) HTML 153K
53: R40 Total Equity (Tables) HTML 381K
54: R41 Earnings per Common Share (Tables) HTML 127K
55: R42 Interest Income and Interest Expense (Tables) HTML 96K
56: R43 Employee Benefit Plans (Tables) HTML 68K
57: R44 Segment and Geographic Information (Tables) HTML 91K
58: R45 Significant Accounting Policies (Details) HTML 47K
59: R46 Fair Value Disclosures (Assets and Liabilities HTML 256K
Measured at Fair Value on a Recurring Basis)
(Details)
60: R47 Fair Value Disclosures (Changes in Level 3 Assets HTML 219K
and Liabilities Measured at Fair Value on a
Recurring Basis) (Details)
61: R48 Fair Value Disclosures (Valuation Techniques and HTML 304K
Sensitivity of Unobservable Inputs Used in
Recurring Level 3 Fair Value Measurements)
(Details)
62: R49 Fair Value Disclosures (Fair Value of Investments HTML 60K
Measured at NAV) (Details)
63: R50 Fair Value Disclosures (Earnings Impact of HTML 66K
Instruments Under to the Fair Value Option)
(Details)
64: R51 Fair Value Disclosures (Gains (Losses) Due to HTML 59K
Changes in Instrument-Specific Credit Risk)
(Details)
65: R52 Fair Value Disclosures (Short-term and Long-term HTML 51K
Borrowings Measured at Fair Value) (Details)
66: R53 Fair Value Disclosures (Net Difference of HTML 43K
Contractual Principal Amount Over Fair Value)
(Details)
67: R54 Fair Value Disclosures (Fair Value of Loans in HTML 41K
Nonaccrual Status) (Details)
68: R55 Fair Value Disclosures (Assets Measured at Fair HTML 81K
Value on a Non-Recurring Basis) (Details)
69: R56 Fair Value Disclosures (Financial Instruments Not HTML 129K
Measured at Fair Value) (Details)
70: R57 Derivative Instruments and Hedging Activities HTML 197K
(Derivative Assets and Liabilities) (Details)
71: R58 Derivative Instruments and Hedging Activities HTML 107K
(Derivative Notionals) (Details)
72: R59 Derivative Instruments and Hedging Activities HTML 76K
(Gains (Losses) on Fair Value Hedges and on
Effective Portion of Net Investment Hedges, and
Trading Revenues) (Details)
73: R60 Derivative Instruments and Hedging Activities HTML 51K
(Credit Risk-Related Contingencies) (Details)
74: R61 Derivative Instruments and Hedging Activities HTML 119K
(Credit Derivatives and Other Credit Contracts)
(Details)
75: R62 Investment Securities (AFS and HTM Securities) HTML 137K
(Details)
76: R63 Investment Securities (Investment Securities in an HTML 154K
Unrealized Loss Position) (Details)
77: R64 Investment Securities (Investment Securities by HTML 204K
Contractual Maturity) (Details)
78: R65 Investment Securities (Gross Realized Gains and HTML 44K
Losses on Sales of AFS Securities) (Details)
79: R66 Collateralized Transactions (Offsetting of Certain HTML 116K
Collateralized Transactions) (Details)
80: R67 Collateralized Transactions (Gross Secured HTML 83K
Financing Balances) (Details)
81: R68 Collateralized Transactions (Assets Pledged) HTML 44K
(Details)
82: R69 Collateralized Transactions (Collateral Received) HTML 42K
(Details)
83: R70 Collateralized Transactions (Customer Margin HTML 38K
Lending and Other) (Details)
84: R71 Collateralized Transactions (Cash and Securities HTML 43K
Deposited with Clearing Organizations or
Segregated) (Details)
85: R72 Loans and Allowance for Credit Losses (Loans Held HTML 125K
for Investment and Held for Sale) (Details)
86: R73 Loans and Allowance for Credit Losses (Impaired HTML 68K
Loans) (Details)
87: R74 Loans and Allowance for Credit Losses (Tdr) HTML 43K
(Details)
88: R75 Loans and Allowance for Credit Losses (Allowance HTML 104K
for Loan Losses and Lending Commitments
Rollforward) (Details)
89: R76 Loans and Allowance for Credit Losses (Employee HTML 48K
Loans) (Details)
90: R77 Equity Method Investments (Equity Method HTML 44K
Investment Balances) (Details)
91: R78 Equity Method Investments (Investees) (Details) HTML 48K
92: R79 Deposits (Details) HTML 62K
93: R80 Long-Term Borrowings and Other Secured Financings HTML 47K
(Long-Term Borrowings) (Details)
94: R81 Long-Term Borrowings and Other Secured Financings HTML 45K
(Other Secured Financings) (Details)
95: R82 Commitments, Guarantees and Contingencies HTML 78K
(Commitments) (Details)
96: R83 Commitments, Guarantees and Contingencies HTML 115K
(Obligations under Guarantee Arrangements)
(Details)
97: R84 Commitments, Guarantees and Contingencies HTML 116K
(Contingencies) (Details)
98: R85 Variable Interest Entities and Securitization HTML 51K
Activities (Consolidated VIEs) (Details)
99: R86 Variable Interest Entities and Securitization HTML 74K
Activities (Assets and Liabilities by Balance
Sheet Caption) (Details)
100: R87 Variable Interest Entities and Securitization HTML 101K
Activities (Non-Consolidated VIEs) (Details)
101: R88 Variable Interest Entities and Securitization HTML 85K
Activities (Transfers of Assets with Continuing
Involvement 1) (Details)
102: R89 Variable Interest Entities and Securitization HTML 70K
Activities (Transfers of Assets with Continuing
Involvement 2) (Details)
103: R90 Variable Interest Entities and Securitization HTML 67K
Activities (Proceeds from retained interests in
securitization transactions) (Details)
104: R91 Variable Interest Entities and Securitization HTML 41K
Activities (Failed Sales) (Details)
105: R92 Regulatory Requirements (Narrative) (Details) HTML 44K
106: R93 Regulatory Requirements (Capital Measures) HTML 79K
(Details)
107: R94 Regulatory Requirements (U.S. Bank Subsidiaries' HTML 84K
Regulatory Capital and Capital Ratios) (Details)
108: R95 Regulatory Requirements (Broker-Dealer Regulatory HTML 46K
Capital Requirements) (Details)
109: R96 Total Equity (Dividends and Share Repurchase) HTML 64K
(Details)
110: R97 Total Equity (Preferred Stock General Disclosure) HTML 57K
(Details)
111: R98 Total Equity (Preferred Stock Outstanding) HTML 82K
(Details)
112: R99 Total Equity (Accumulated Other Comprehensive HTML 64K
Income (Loss)) (Details)
113: R100 Total Equity (Period Changes in OCI Components) HTML 175K
(Details)
114: R101 Total Equity (Noncontrolling Interests) (Details) HTML 38K
115: R102 Earnings per Common Share (Calculation of Basic HTML 104K
and Diluted EPS) (Details)
116: R103 Interest Income and Interest Expense (Details) HTML 68K
117: R104 Employee Benefit Plans (Net Periodic Benefit HTML 53K
Expense (Income)) (Details)
118: R105 Segment and Geographic Information (Selected HTML 82K
Financial Information by Segments) (Details)
119: R106 Segment and Geographic Information HTML 38K
(Performance-based Fees at Risk) (Details)
120: R107 Segment and Geographic Information (Assets by HTML 46K
Business Segment) (Details)
121: R108 Segment and Geographic Information (Net Revenues HTML 46K
and Total Assets by Region) (Details)
123: XML IDEA XML File -- Filing Summary XML 249K
122: EXCEL IDEA Workbook of Financial Reports XLSX 205K
8: EX-101.INS XBRL Instance -- ms-20170930 XML 16.67M
10: EX-101.CAL XBRL Calculations -- ms-20170930_cal XML 591K
11: EX-101.DEF XBRL Definitions -- ms-20170930_def XML 3.36M
12: EX-101.LAB XBRL Labels -- ms-20170930_lab XML 6.44M
13: EX-101.PRE XBRL Presentations -- ms-20170930_pre XML 4.47M
9: EX-101.SCH XBRL Schema -- ms-20170930 XSD 631K
124: ZIP XBRL Zipped Folder -- 0001193125-17-331902-xbrl Zip 964K
 | Download this zipped .zip folder |
| Files: | ms-20170930.xml ms-20170930.xsd ms-20170930_cal.xml ms-20170930_def.xml ms-20170930_lab.xml ms-20170930_pre.xml |